The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal

Pedro Coelho Barata; Diogo Alpuim Costa; José Luís Passos Coelho; Ricardo Da Luz

doi:10.20344/amp.9969

The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal

Authors

Pedro Coelho Barata Taussig Cancer Institute Cleveland Clinic. Cleveland.
Diogo Alpuim Costa Instituto CUF de Oncologia (I.C.O.) Lisboa
José Luís Passos Coelho Hospital Beatriz Ângelo. Loures.
Ricardo Da Luz Centro Hospitalar De Lisboa Central. Lisboa.

DOI:

https://doi.org/10.20344/amp.9969

Keywords:

Antineoplastic Agents/economics, Carcinoma, Renal Cell/therapy, Drug Costs, Neoplasm Metastasis, Portugal

Abstract

N/A.

Downloads

Download data is not yet available.

Author Biography

Pedro Coelho Barata, Taussig Cancer Institute Cleveland Clinic. Cleveland.

Experimental Therapeutics Fellow, Cleveland Clinic. Cleveland

Downloads

Published

2018-08-31

How to Cite

Barata PC, Costa DA, Passos Coelho JL, Da Luz R. The Costly War Against Cancer Treatment: The Example of Metastatic Renal Cell Carcinoma in Portugal. Acta Med Port [Internet]. 2018 Aug. 31 [cited 2024 Nov. 18];31(7-8):373-5. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/9969

Download Citation

Issue

Vol. 31 No. 7-8 (2018): July-August

Section

Perspective

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.